LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy

Br J Haematol. 2020 Jun;189(6):e248-e251. doi: 10.1111/bjh.16679. Epub 2020 Apr 27.
No abstract available

Keywords: diffuse large B cell lymphoma; polatuzumab; pseudo-progression.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Immunoconjugates*
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Salvage Therapy

Substances

  • Antibodies, Monoclonal
  • Immunoconjugates
  • polatuzumab vedotin